Cannabis Kapruvia® approved in Switzerland with additional regulatory decisions expected in H2 2022 August 19, 2022
Technology Independent Proxy Advisory Firm Glass Lewis Recommends that Ceragon Shareholders Vote for Change August 19, 2022
Biotech BridgeBio Pharma Announces Dosing of First Patient in Phase 1 Trial of BBP-671, a Potential Best-In-Class Treatment for Propionic Acidemia (PA) and Methylmalonic Acidemia (MMA) August 18, 2022
Biotech NGM Bio Provides Business Highlights and Reports Second Quarter 2022 Financial Results August 18, 2022
Biotech Chinook Therapeutics Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) August 18, 2022